Advertisement
Advertisement
U.S. markets open in 7 hours 48 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed Price. Currency in USD
125.79-1.29 (-1.02%)
At close: 04:00PM EST
126.00 +0.21 (+0.17%)
After hours: 07:29PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close127.08
Open126.00
Bid0.00 x 900
Ask0.00 x 900
Day's Range124.87 - 126.58
52 Week Range91.51 - 127.79
Volume1,217,149
Avg. Volume1,276,059
Market Cap283.17B
Beta (5Y Monthly)0.34
PE Ratio (TTM)38.35
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.60 (1.26%)
Ex-Dividend DateAug 12, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-1% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NVO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Novo Nordisk A/S
    Analyst Report: Novo Nordisk A/SWith almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
    Rating
    Fair Value
    Economic Moat
    18 days agoMorningstar
View more
Advertisement
Advertisement